DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/13913
Full metadata record
DC FieldValueLanguage
dc.contributor.authorXiu, Yuanyuan-
dc.contributor.authorJia, Lijing-
dc.contributor.authorChen, Jianbin-
dc.contributor.authorCui, Wei-
dc.date.accessioned2022-11-03T10:11:02Z-
dc.date.available2022-11-03T10:11:02Z-
dc.date.issued2017-05-20-
dc.identifier.citationXiu, Y., Jia, L., Chen, J., & Cui, W. (2017). Research on hospital drug cost control based on the perspective of pharmaceutical economy. Pakistan Journal of Pharmaceutical Sciences, 30.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/13913-
dc.description.abstractIn recent years, the continuous growth of drug costs has become one of the hot issues of society. In this paper, by using principles and methods of pharmacoeconomics, we study on the management of drug cost control in hospital. Pharmacoeconomics involves the effective allocation and rational use of drug resources, and study the economic effect, that is to carry out the study of drug resources utilization efficiency. Through the analysis of the cost-benefit analysis of drug treatment, we could find the a more cost-effective treatment. Pharmacoeconomics can be applied to the clinical diagnosis and treatment, make reasonable prescription cost effect, it could provide patients with high economic efficiency of treatment, so that drug treatment to achieve the best results.en_US
dc.language.isoenen_US
dc.publisherKarachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.en_US
dc.subjectDrug cost controlen_US
dc.subjectpharmaceutical economyen_US
dc.subjectcost benefit analysisen_US
dc.titleResearch on hospital drug cost control based on the perspective of pharmaceutical economyen_US
dc.typeArticleen_US
Appears in Collections:No.3(Special),May2017

Files in This Item:
File Description SizeFormat 
4-SP-5655.htm192 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.